GJA1 and familial long QT syndrome: The present study demonstrated that the gap junction enhancer, AAP10, significantly reduces Tp-e and Tp-e/QT and prevents TdP by inhibiting the dephosphorylation of Cx43 in ibutilide-induced LQTS.